A-Kinase Anchoring Protein Targeting of Protein Kinase A and Regulation of HERG Channels

Adrenergic stimulation of the heart initiates a signaling cascade in cardiac myocytes that increases the concentration of cAMP. Although cAMP elevation may occur over a large area of a target-organ cell, its effects are often more restricted due to local concentration of its main effector, protein kinase A (PKA), through A-kinase anchoring proteins (AKAPs). The HERG potassium channel, which produces the cardiac rapidly activating delayed rectifying K+ current (IKr), is a target for cAMP/PKA regulation. PKA regulation of the current may play a role in the pathogenesis of hereditary and acquired abnormalities of the channel leading to cardiac arrhythmia. We examined the possible role for AKAP-mediated regulation of HERG channels. Here, we report that the PKA-RII-specific AKAP inhibitory peptide AKAP-IS perturbs the distribution of PKA-RII and diminishes the PKA-dependent phosphorylation of HERG protein. The functional consequence of AKAP-IS is a reversal of cAMP-dependent regulation of HERG channel activity. In further support of AKAP-mediated targeting of kinase to HERG, PKA activity was coprecipitated from HERG expressed in HEK cells. Velocity gradient centrifugation of solubilized porcine cardiac membrane proteins showed that several PKA-RI and PKA-RII binding proteins cosediment with ERG channels. A physical association of HERG with several specific AKAPs with known cardiac expression, however, was not demonstrable in heterologous cotransfection studies. These results suggest that one or more AKAP(s) targets PKA to HERG channels and may contribute to the acute regulation of IKr by cAMP

Theory of coupled ion-electron transfer kinetics

The microscopic theory of chemical reactions is based on transition state theory, where atoms or ions transfer classically over an energy barrier, as electrons maintain their ground state. Electron transfer is fundamentally different and occurs by tunneling in response to solvent fluctuations. Here, we develop the theory of coupled ion-electron transfer, in which ions and solvent molecules fluctuate cooperatively to facilitate electron transfer. We derive a general formula of the reaction rate that depends on the overpotential, solvent properties, the electronic structure of the electron donor/acceptor, and the excess chemical potential of ions in the transition state. For Faradaic reactions, the theory predicts curved Tafel plots with a concentration-dependent reaction-limited current. For moderate overpotentials, our formula reduces to the Butler-Volmer equation and explains its relevance, not only in the well-known limit of large electron-transfer (solvent reorganization) energy, but also in the opposite limit of large ion-transfer energy. The rate formula is applied to Li-ion batteries, where reduction of the electrode host material couples with ion insertion. In the case of lithium iron phosphate, the theory accurately predicts the concentration dependence of the exchange current measured by {\it in operando} X-Ray microscopy without any adjustable parameters. These results pave the way for interfacial engineering to enhance ion intercalation rates, not only for batteries, but also for ionic separations and neuromorphic computing

Cartilage diseases

Hyaline cartilages, fibrocartilages and elastic cartilages play multiple roles in the human body including bearing loads in articular joints and intervertebral discs, providing joint lubrication, forming the external ears and nose, supporting the trachea, and forming the long bones during development and growth. The structure and organization of cartilage's extracellular matrix (ECM) are the primary determinants of normal function. Most diseases involving cartilage lead to dramatic changes in the ECM which can govern disease progression (e.g., in osteoarthritis), cause the main symptoms of the disease (e.g., dwarfism caused by genetically inherited mutations) or occur as collateral damage in pathological processes occurring in other nearby tissues (e.g., osteochondritis dissecans and inflammatory arthropathies). Challenges associated with cartilage diseases include poor understanding of the etiology and pathogenesis, delayed diagnoses due to the aneural nature of the tissue and drug delivery challenges due to the avascular nature of adult cartilages. This narrative review provides an overview of the clinical and pathological features as well as current treatment options available for various cartilage diseases. Late breaking advances are also described in the quest for development and delivery of effective disease modifying drugs for cartilage diseases including osteoarthritis, the most common form of arthritis that affects hundreds of millions of people worldwide. Keywords: Extracellular matrix, Cartilage, Diseases of cartilage, Growth plate fractures, Genetic disorders involving cartilage, Osteochondritis dissecans, Relapsing polychondritis, Chondrocalcinosis, Pseudogout cartilaginous tumors, Inflammatory arthropathies, OsteoarthritisPost-traumatic osteoarthritis, Cartilage ECM-targeted drug carriersNational Institute of Biomedical Imaging and Bioengineering (U.S.) (NIH NIBIB grant EB017755)National Science Foundation (U.S.). Materials Research Science and Engineering Centers ((MRSEC) grant DMR-1419807)National Institute of Arthritis and Musculoskeletal and Skin Diseases (U.S.) (NIH NIAMS grant AR060331)Congressionally Directed Medical Research Programs (U.S.) (CDMRP grant W81XWH-14-1-0544)National Center for Advancing Translational Sciences (U.S.) (NIH/NCATS grant UG3 TR002186

Primary mediastinal large B-cell lymphoma: Clinical features, prognostic factors and survival with RCHOP in Arab patients in the PET scan era

Objective: PMBCL is a distinct type of nonhodgkins lymphoma with specific clinicopathological features. To clarify clinical features, treatment alternatives and outcomes, we evaluated 28 Arab patients treated with chemotherapy or radiotherapy between 2006 and 2011. Patients and Methods: PMBCL lymphoma patients identified according to WHO classification and treated at KCCC between 2006 and 2011 were included in this study. Demographic and clinical data are presented as means or medians. Overall survival was estimated using the Kaplan-Meier method. Survival rates were compared using the log-rank test. A P < 0.05 was considered significant. Results: The median age of the patients was 31 years and the male to female ratio was 2:1. Majority of the patients (75%) presented with stage I/II disease. Most had features of local extension like pleural effusion (18%) and SVCO (39%). Only 11% of the patients had bone marrow involvement at presentation. 96% of the patients required biopsy from the mediastinal mass either by image guided core biopsy (75%) or by surgical biopsy. Most patients were treated by RCHOP and involved field radiotherapy. Patients with positive PET scan after RCHOP chemotherapy received salvage chemotherapy and BEAM autologous marrow transplant. The five year OS for the entire group was 85% while the PFS was 73%. Patients who had PET scan for response evaluation had better OS [P = 0.013] and PFS [P = 0.039] when compared with those patients who received only radiotherapy based on CT scan evaluation. Conclusion: PMBCL is a specific lymphoma entity seen in the young with good survival. The role of PET scan for response evaluation and the type of consolidation therapy needs to be further clarifie

PKA phosphorylation of HERG protein regulates the rate of channel synthesis

Acute changes in cAMP and protein kinase A (PKA) signaling can regulate ion channel protein activities such as gating. Effects on channels due to chronic PKA signaling, as in stress or disease states, are less understood. We examined the effects of prolonged PKA activity on the human ether-a-go-go-related gene (HERG) K+ channel in stably transfected human embryonic kidney (HEK)293 cells. Sustained elevation of cAMP by either chlorophenylthiol (CPT)-cAMP or forskolin increased the HERG channel protein abundance two- to fourfold within 24 h, with measurable difference as early as 4 h. The cAMP-induced augmentation was not due to changes in transcription and was specific for HERG compared with other cardiac K+ channels (Kv1.4, Kv1.5, Kir2.1, and KvLQT1). PKA activity was necessary for the effect on HERG protein and did not involve other cAMP signaling pathways. Direct PKA phosphorylation of the HERG protein was responsible for the cAMP-induced augmentation. Enhanced abundance of HERG protein was detected in endoplasmic reticulum-enriched, Golgi, and plasma membrane without significant changes in trafficking rates or patterns. An increase in the K+ current density carried by the HERG channel was also observed, but with a delay, suggesting that traffic to the surface is rate-limiting traffic. Acceleration of the HERG protein synthesis rate was the primary factor in the cAMP/PKA effect with lesser effects on protein stability. These results provide evidence for a novel mechanism whereby phosphorylation of a nascent protein dictates its rate of synthesis, resetting its steady-state abundance

Public perception on childhood cancers from a population-based study in South India: Lessons to learn to avoid stigma

Background: The probability of survival for childhood cancer in several low- and middle-income countries (LMIC) is less than 30%. Myths and misconceptions among the general public concerning childhood cancers have detrimental effects on early detection and treatment. Materials and methods: This study aimed to assess public perceptions of childhood cancer among the public. We conducted a cross-sectional survey with 310 respondents by using an interview schedule. Results: Most (n = 244, 79.7%) participants were aware of the occurrence of childhood cancer in the community and the curability of cancer in children. The respondents’ knowledge was mainly derived from online media (television, cinema, or social media). Most (n = 189, 61.8%) respondents knew that blood cancer was the most common malignancy among children. Among the causative factors, the infectious nature, environmental factors, and curse of god were perceived as reasons by 19.6%, 29%, and 33% of the subjects, respectively. Half of the cohort felt that the child would never return to normal life after treatment completion. The reasons for hesitancy to treat even after knowing the curability of the disease were fear of treatment expenses, wrong beliefs, wrong/lack of information, fear of adverse effects, and lack of family support. Conclusion: Despite the advances in the diagnosis and treatment of childhood cancers, cancer remains a stigma in our community, interfering with the reintegration process of children into society, which is a significant barrier to improving survival